We measured the levels of serum thyroglobulin (Tg) in 52 pregnant females at various stages and compared them with those of 15 age-matched nonpregnant females. Serum Tg was measured by a solid-phase immunoradiometric assay. In pregnant females, mean serum Tg levels at the first, second, early third, and late third trimesters were 8.4 (range; 1.3-18.0), 9.2 (1.7-25.6), 10.1 (1.8-22.8), and 12.1ng/ml (5.3-25.2), respectively. The statistical comparison was made after logarithmic transformation of the data. The mean value only at the late third trimester was significantly higher than that of controls (mean; 6.0ng/ml, range; 1.5-23.6), but each value was within the normal range. Although serum Tg levels have been reported to be high at the end of pregnancy, our results indicate that the Tg levels in females could be clinically interpreted without regard to the coexistence of pregnancy.
Recent progress in radioimmunoassay (RIA) technology has shown that thyroglobulin (Tg) is a protein normally secreted by the thyroid gland (Van Herle et al., 1979) and can be detected in the serum of virtually all normal subjects (Roitt and Torrigiani, 1967; Van Herle et al., 1973; Pezzino et al., 1977; Bodlaender et al., 1978; Roti et al., 1981) . The clinical usefulness of measuring serum Tg levels in thyroidal and nonthyroidal disorders has been pointed out by many workers. For example, high levels of serum Tg have been reported in patients with Graves' disease (Van Herle et al., 1973; Izumi and Larsen, 1978; Gardner et al., 1979; Pacini et al., 1980) , subacute thyroiditis (Van Herle et al., 1973; Izumi and Larsen, 1978; Gardner et al., 1979; Pacini et al., 1980) , and differentiated thyroid carcinoma (Van Herle and Uller, 1975; Shlossberg et al., 1979; Pacini et al., 1980) , whereas the suppression of serum Tg levels in thyrotoxicosis factitia has been reported (Mariotti et al., 1982) .
Elevated levels of serum Tg have also been reported in normal pregnant women at the third trimester (Torrigiani et al., 1969) and at delivery (Van Herle et al., 1973; Pacini et al., 1980; Roti et al., 1981) . However, there has been little information concerning the level of serum Tg in each trimester of normal pregnancy. Therefore, it is not clear whether the levels of serum Tg in pregnant women can be used in the assessment of the clinical states of thyroidal disorders. subjects showed an approximately normal distribution in the logarithmic scale (Van Herle et al., 1976; Nakamura et al., 1984) . The Mann and Whitney U test was per formed using the native values for Tg (Pezzino et. al., 1977; Nakamura et al., 1984) . Differences were considered to be significant if p was less than 0.05. Mean values in the results were calculated from the levels of log Tg.
Results Figure 1 shows the concentrations of serum Tg obtained from 52 pregnant and 15 nonpregnant females. Table 1 shows the mean logarithms for serum Tg and the range. The mean serum Tg concentration calculated from the logarithms for serum Tg of nonpregnant control females was 6.0ng/ml with a range of 1.5 to 23.6ng/ml.
For pregnant women, the mean serum Tg levels at the first, second, early third, and the late third trimesters were 8.4 (range 1.3-18.0), 9.2 (1.7-25.6), 10.1 (1.8-22.8), and 12.1ng/ml (5.3-25.2), respectively. The variation of log Tg levels in the control group was not significantly different from that of the 4 pregnant groups.
The mean value at the late third trimester was significantly higher (p<0.05 in both statistical analyses) than that of the controls. On the other hand, each mean value at the first, second, and early third 
Discussion
Virtually all aspects of thyroid hormone economy are affected by pregnancy. For example, it is well known that T3 and T4 steadily increase during the first trimester and remain at high levels thereafter (Chan et al., 1975; Yamamoto et al., 1979; Skjoldebrand et al., 1982) .
Concerning the values for serum Tg in normal pregnant women, only a few reports have been published.
An earlier report by Hjort and Pedersen (1962) using a semiquantitative hemagglutination-inhibition technique showed that serum Tg was not detected in nonpregnant women but was detected in 3, 11, and 50% of pregnant women at the end of the first trimester, at six weeks before delivery, and at delivery, respectively. Torrigiani et al. (1969) , using RIA, compared the serum Tg levels of nonpregnant women with those of pregnant women at the first and third trimesters. In their study, there was no significant rise in Tg at the first trimester, but at the third trimester a significant rise in serum Tg levels was observed. In our study, the mean serum Tg concentration was significantly higher only at the late third trimester of pregnancy than that of controls. The fact that serum Tg levels rise toward the end of pregnancy is supported by the studies of Van Herle et al. (1973) , Pacini et al. (1980) , and Roti et al. (1981) .
Concerning the degree of rise in Tg at the end of the pregnancy, controversy still exists. Roti et al. (1981) reported that Tg levels of term pregnant women were about 4 times higher than those of controls. On the other hand, Van Herle et al. (1973) reported that the difference was slight.
We could not find any significant change in Tg levels at the first and second trimester. This is apparently in contrast with the report of Hjort and Pedersen (1962) . However, their method was a semiquantitative hemagglutination method and less precise than the present method.
Van Herle et al. (1973) reported that the elevated serum Tg levels in pregnant women at delivery might be related to human chorionic thyrotropin (hCT) in the maternal circulation. Recent data (Harada et al., 1978 and 1979) , however, do not support the view because the thyrotropic activity of so-called hCT is quesitonable. At present, the mechanism(s) that causes the elevation of the serum Tg concentration in pregnant women at the late third trimester is still obscure.
Recently, it has been shown that determinations of serum Tg concentrations could provide useful information concerning the recurrence of thyroid carcinoma (Van Herle and Uller, 1975; Shlossberg et al., 1979; Pacini et al., 1980) and the decision to discontinue antithyroid drug in the treatment of Graves' disease (Kawamura et al., 1983) . From the results of the present study, it is concluded that pregnancy per se does not likely cause misinterpretation of the evaluation of the Tg level in patients with thyroid disease, since (1) the serum Tg level in pregnant females at the first, second, and early third trimesters is not different from that of controls and (2) the mean serum Tg level in pregnant females at the late third trimester is only slightly higher than that of controls when compared with the clearly elevated Tg level in patients with thyroid disease (Van Herle et al., 1973 and Izumi and Laysen 1978; Gardner et al., 1979; Shlossberg et al., 1979; Pacini et al., 1980) .
